HLOSF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

HEALIOS K K (HLOSF) Ownership - Who owns HEALIOS K K?

Healios KK is involved in development and sales of opthalmological surgery adjuvants and research, development and manufacture of cell therapy products and regenerative medicine products... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

World Trade Center Bldg. 15th Floor

Phone

N/A

Employees

108

Web

https://www.healios.co.jp

Details

Group

Domestic Stock Funds

Fundamentals

HLOSF

Capitalization

148M

P/E Ratio

N/A

Risk (Beta)

-0.95

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.04%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

14.29

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

66.9M

Shares Outstanding - Current

101M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

-1

Gain YTD

43.704

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology